- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Pressure and Hypertension Studies
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Structural Anomalies and Repair
- Chronic Kidney Disease and Diabetes
- Venous Thromboembolism Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Acute Kidney Injury Research
- Cardiac Arrest and Resuscitation
- Cardiac Valve Diseases and Treatments
- Mechanical Circulatory Support Devices
- Cardiac Health and Mental Health
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac electrophysiology and arrhythmias
- Acute Ischemic Stroke Management
- Lipoproteins and Cardiovascular Health
- Health Systems, Economic Evaluations, Quality of Life
- Hormonal Regulation and Hypertension
Complejo Hospitalario Universitario de Santiago
2015-2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2017-2024
Centro de Investigación Biomédica en Red
2017-2024
Universidade de Santiago de Compostela
2013-2023
Lankenau Institute for Medical Research
2023
Medical Research Network
2021-2022
Complexo Hospitalario Universitario A Coruña
1998-2021
Instituto de Investigación Sanitaria de Santiago
2006-2021
Centre for Biomedical Network Research on Rare Diseases
2021
Servicio Gallego de Salud
2019-2021
Background: The prevalence and outcome of patients with cancer that experience acute coronary syndrome (ACS) have to be determined. Methods results: BleeMACS project is a multicentre observational registry enrolling undergoing percutaneous intervention worldwide in 15 hospitals. primary endpoint was composite event death re-infarction after one year follow-up. Bleedings were the secondary endpoint. 15,401 enrolled, 926 (6.4%) group 14,475 (93.6%) without cancer. Patients older (70.8±10.3 vs....
Background Takotsubo syndrome ( TTS ) is an acute reversible heart condition initially believed to represent a benign pathology attributable its self‐limiting clinical course; however, little known about prognosis based on different triggers. This study compared short‐ and long‐term outcomes between triggers, focusing various physical triggering events. Methods Results We analyzed patients with definitive diagnosis recruited for the Spanish National Registry (RETAKO [Registry Syndrome])....
Haemorrhagic complications are strongly linked with adverse outcomes in acute coronary syndrome (ACS) patients. Various risk scores (RS) available to predict bleeding these We compared the performance of three contemporary RS ACS.We studied 4500 consecutive patients ACS. calculated ACTION, CRUSADE, and Mehran et al. (2010) RS, evaluated their for predicting own major events TIMI serious (major or minor) episodes, either non-ST-elevation ACS (NSTEACS) ST-elevation myocardial infarction...
Abstract Background Remnant cholesterol has been identified as one of leading lipid values associated with the incidence coronary heart disease. There is scarce evidence on its distribution and prognostic value in acute syndrome (ACS) patients. Methods results We included all consecutive patients admitted for ACS two different centres. was calculated by equation: total minus LDL HDL cholesterol, ≥30 were considered high. Among 7479 patients, median remnant level 28 mg/dL (21–39), 3429...
Advanced glycation end products (AGEs) have pathophysiological implications in cardiovascular diseases. The aim of our study was to evaluate the prognostic value fluorescent AGEs and its soluble receptor (sRAGE) context acute coronary syndrome (ACS), both in-hospital phase follow-up period.A prospective clinical performed patients with debut's ACS. endpoints were development cardiac events (cardiac deaths, re-infarction new-onset heart failure) during period (366 days, inter-quartile range:...
No evidence-based therapy has yet been established for Takotsubo syndrome (TTS). Given the putative harmful effects of catecholamines in patients with TTS, beta-blockers may potentially decrease intensity detrimental cardiac those patients. The purpose this study was to assess impact beta-blocker on long-term mortality and TTS recurrence. cohort used national Spanish Registry TakoTsubo Syndrome (RETAKO). A total 970 post-discharge survivors, without pheochromocytoma, left ventricular outflow...
The benefit of complete or incomplete percutaneous coronary intervention (PCI) in patients with myocardial infarction and multivessel disease remains debated. aim our study was to compare a vs. "culprit only" revascularisation strategy distinguishing the different clinical subsets (STEMI NSTEMI) provide one-year outcome from "real-life" BleeMACS (Bleeding complications Multicenter registry discharged diagnosis Acute Coronary Syndrome) registry.We conducted multicentre including all included...